Search

1244447
1240861
1230819
1195994
393884
Final results from M72 AS01E TB Vaccine Trial
The final results from the M72AS01E TB vaccine study have been published in the New England Journal of Medicine. The vaccine demonstrated a 50% efficacy rate in the incidence of lung TB disease in HIV-negative adults, already infected with latent...
Beat TB drama production
Beat TB, a Welcome Trust funded street theater production which raised awareness about tuberculosis (TB) and vaccine research understanding amongst the broader public of the Worcester area. during 2016.
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
New multi-functional TB blood test validated
Researchers the South African Tuberculosis Vaccine Initiative (SATVI), the Center for Global Infectious Disease Research(USA) and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to...
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...

News

Monday, 2 August 2021
6 July 2021 Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis

SATVI researchers have published a journal article titled: "Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis" appearing in the Lancet Microbe journal.

Publication Date:
Thu, 15 Jul 2021 - 12:45
20 June 2021 Research published: Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV

SATVI researchers have published journal article titled: "Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial" appearing in The Lancet Infectious Diseases journal.

Publication Date:
Thu, 15 Jul 2021 - 12:15
18 June 2021 Research published: HLA-DR marks recently divided antigen-apecific effector CD4 T Cells in active Tuberculosis patients

SATVI researchers have published a journal article titled "HLA-DR Marks recently divided Antigen-Specific effector CD4 T Cells in active Tuberculosis patients" appearing in the EBioMedicine journal.

Publication Date:
Wed, 14 Jul 2021 - 10:45
17 June 2021 Vacancy: Postdoctoral Fellowship in Single Cell Immunology

The South African Tuberculosis Vaccine Initiative is inviting applications for a Postdoctoral Fellowship in Single Cell Immunology. Closing date 30 August 2021.

Publication Date:
Thu, 17 Jun 2021 - 16:00

Pages